UnitedHealth Group (NYSE:UNH) Given New $386.00 Price Target at Barclays

Key Points

• Barclays raised its price target for UnitedHealth Group from $352.00 to $386.00, reflecting a potential upside of 3.63% from the current stock price.
• Several other analysts have also adjusted their price targets, with Morgan Stanley setting a new target of $395.00 and Oppenheimer lowering theirs to $325.00.
• Currently, 16 analysts rate the stock as a Buy, while others provide Hold and Sell ratings, indicating a mixed outlook for the healthcare giant.

UnitedHealth Group (NYSE:UNH - Get Free Report) had its price target upped by research analysts at Barclays from $352.00 to $386.00 in a research note issued on Thursday,Benzinga reports. The brokerage presently has an "overweight" rating on the healthcare conglomerate's stock. Barclays's price target points to a potential upside of 3.63% from the company's current price.

UNH has been the topic of several other reports. Morgan Stanley upped their price target on shares of UnitedHealth Group from $325.00 to $395.00 and gave the company an "overweight" rating in a report on Friday, September 12th. Oppenheimer decreased their price target on UnitedHealth Group from $400.00 to $325.00 and set an "outperform" rating for the company in a research note on Wednesday, July 30th. Robert W. Baird reiterated an "underperform" rating and set a $198.00 target price (down from $312.00) on shares of UnitedHealth Group in a research report on Thursday, July 31st. Wells Fargo & Company raised their price target on shares of UnitedHealth Group from $267.00 to $400.00 and gave the stock an "overweight" rating in a research note on Tuesday. Finally, UBS Group restated a "buy" rating on shares of UnitedHealth Group in a research note on Thursday, July 17th. Sixteen investment analysts have rated the stock with a Buy rating, seven have given a Hold rating and four have assigned a Sell rating to the company's stock. According to MarketBeat, the stock currently has an average rating of "Hold" and an average target price of $377.86.

UnitedHealth Group Trading Up 0.7%

Shares of NYSE UNH opened at $372.48 on Thursday. The stock has a market capitalization of $337.35 billion, a P/E ratio of 16.09, a PEG ratio of 2.35 and a beta of 0.47. UnitedHealth Group has a 1-year low of $234.60 and a 1-year high of $630.73. The business's 50 day moving average is $313.51 and its two-hundred day moving average is $352.54. The company has a debt-to-equity ratio of 0.73, a current ratio of 0.85 and a quick ratio of 0.85.

UnitedHealth Group (NYSE:UNH - Get Free Report) last released its earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing the consensus estimate of $4.45 by ($0.37). UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The company had revenue of $111.62 billion for the quarter, compared to the consensus estimate of $111.75 billion. During the same period in the prior year, the firm posted $6.80 EPS. The business's revenue for the quarter was up 12.9% compared to the same quarter last year. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. As a group, research analysts expect that UnitedHealth Group will post 29.54 EPS for the current year.

Institutional Trading of UnitedHealth Group

A number of institutional investors have recently made changes to their positions in UNH. Vanguard Group Inc. raised its stake in UnitedHealth Group by 6.6% in the first quarter. Vanguard Group Inc. now owns 90,729,585 shares of the healthcare conglomerate's stock valued at $47,519,620,000 after buying an additional 5,583,343 shares during the last quarter. Wellington Management Group LLP raised its position in shares of UnitedHealth Group by 10.6% in the 1st quarter. Wellington Management Group LLP now owns 25,847,940 shares of the healthcare conglomerate's stock valued at $13,537,859,000 after purchasing an additional 2,486,839 shares during the last quarter. Geode Capital Management LLC grew its position in UnitedHealth Group by 3.3% during the 2nd quarter. Geode Capital Management LLC now owns 21,312,182 shares of the healthcare conglomerate's stock worth $6,624,411,000 after purchasing an additional 675,075 shares during the last quarter. Norges Bank purchased a new position in shares of UnitedHealth Group in the second quarter worth $3,837,207,000. Finally, Dodge & Cox raised its stake in UnitedHealth Group by 117.7% in the 2nd quarter. Dodge & Cox now owns 8,750,560 shares of the healthcare conglomerate's stock worth $2,729,912,000 after acquiring an additional 4,730,192 shares during the last quarter. Institutional investors and hedge funds own 87.86% of the company's stock.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.